22.02.2024
Share this video ASH 2023 | Secondary-type mutations do not impact the favorable prognosis in NPM1-mutated AML
Christoph Röllig, MD, MSc, Dresden University of Technology, Dresden, Germany, presents a retrospective analysis exploring the impact of secondary-type mutations on the favorable prognosis linked to NPM1...
Quelle: vjhemonc.com